MedPath

Peanut

Generic Name
Peanut
Brand Names
Palforzia 12 Mg (level 3), Palforzia 120 Mg (level 7), Palforzia 160 Mg (level 8), Palforzia 20 Mg (level 4), Palforzia 200 Mg (level 9), Palforzia 240 Mg (level 10), Palforzia 3 Mg (level 1), Palforzia 300 Mg (level 11), Palforzia 40 Mg (level 5), Palforzia 6 Mg (level 2), Palforzia 80 Mg (level 6), Palforzia Initial Dose Escalation
Drug Type
Biotech
Unique Ingredient Identifier
QE1QX6B99R
Background

Peanut allergenic extract is used in allergenic testing.

Clinical Trials
Related News

Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study

Phase 2
Completed
Conditions
Treatment Efficacy
Interventions
First Posted Date
2017-11-17
Last Posted Date
2021-10-29
Lead Sponsor
Johns Hopkins University
Target Recruit Count
7
Registration Number
NCT03345160
Locations
🇺🇸

Johns Hopkins, Baltimore, Maryland, United States

Salvage Peanut Oral Immunotherapy Study

Phase 1
Completed
Conditions
Peanut Allergy
Interventions
First Posted Date
2017-08-16
Last Posted Date
2023-01-30
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
15
Registration Number
NCT03251508
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children

Phase 3
Conditions
Peanut Allergy
Interventions
First Posted Date
2017-01-06
Last Posted Date
2020-12-02
Lead Sponsor
DBV Technologies
Target Recruit Count
300
Registration Number
NCT03013517
Locations
🇮🇪

Clinical Investigations Unit, Cork, Ireland

🇦🇺

Princess Margaret Hospital for Children, Perth, Australia

🇺🇸

Stanford University School of Medicine, Stanford, California, United States

and more 28 locations

High Threshold Peanut Challenge Study

Completed
Conditions
Peanut Allergy
Interventions
Other: Toasted oat flour
First Posted Date
2016-03-03
Last Posted Date
2019-10-03
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
20
Registration Number
NCT02698033

FARE Peanut SLIT and Early Tolerance Induction

Phase 2
Completed
Conditions
Food Hypersensitivity
Peanut Allergy
Peanut Hypersensitivity
Food Allergy
Interventions
First Posted Date
2014-12-02
Last Posted Date
2022-01-10
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
50
Registration Number
NCT02304991
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

Phase 2
Completed
Conditions
Peanut Allergy
Interventions
First Posted Date
2014-04-03
Last Posted Date
2019-09-04
Lead Sponsor
Stanford University
Target Recruit Count
120
Registration Number
NCT02103270
Locations
🇺🇸

Sean N. Parker Center for Allergy Research at Stanford University, Mountain View, California, United States

The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy

Phase 1
Terminated
Conditions
Peanut Allergy
Interventions
First Posted Date
2013-07-11
Last Posted Date
2018-07-03
Lead Sponsor
Johns Hopkins University
Target Recruit Count
5
Registration Number
NCT01897077
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Oral Peanut Immunotherapy for Peanut Allergic Patients

Early Phase 1
Completed
Conditions
Peanut Hypersensitivity
Interventions
First Posted Date
2013-07-02
Last Posted Date
2015-06-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
36
Registration Number
NCT01891136
Locations
🇺🇸

UNC Chapel Hill, Chapel Hill, North Carolina, United States

Tolerance Following Peanut Oral Immunotherapy

Phase 1
Completed
Conditions
Peanut Allergy
Interventions
First Posted Date
2012-12-17
Last Posted Date
2021-07-28
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
41
Registration Number
NCT01750879
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Oral Peanut Immunotherapy

Not Applicable
Completed
Conditions
Peanut Allergy
Interventions
First Posted Date
2011-03-29
Last Posted Date
2018-08-08
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
30
Registration Number
NCT01324401
Locations
🇺🇸

Food Allergy Center; Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy